The latest medical research on Neuroendocrine Tumors
The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about neuroendocrine tumors gathered by our medical AI research bot.
The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.
Want more personalised results?
Request AccessFriend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancer.
Neuroendocrine TumorsInhibiting the activity of the androgen receptor (AR) is the cornerstone treatment for advanced prostate cancer. AR-targeted therapies are highly e...
The complex landscape of luminal breast cancer.
Neuroendocrine TumorsThe breast epithelium, vital for mammary gland function, is influenced by oestrogen through the ER signalling pathway. Luminal breast cancer, chara...
Living with a RET gene mutation: patient perspectives.
Neuroendocrine TumorsMultiple endocrine neoplasia type 2 (MEN2) is the collective term for 2 distinct types of autosomal dominantly inherited neuroendocrine neoplasm (N...
Chromosomal Alteration Patterns in PitNETs: Massive Losses in Aggressive Tumors.
Neuroendocrine TumorsThe molecular biology of pituitary neuroendocrine tumors (PitNETs) revealed few recurrent mutations and extensive chromosomal alterations, with the...
Cellular Mechanisms of RET Receptor Dysfunction in Multiple Endocrine Neoplasia 2.
Neuroendocrine TumorsREarranged during Transfection (RET) is a developmentally important receptor tyrosine kinase that has been identified as an oncogenic driver in a n...
In Memoriam: Charis Eng, M.D., Ph.D. (1962-2024).
Neuroendocrine TumorsMatthew Ringel On behalf of the entire editorial team of Endocrine-Related Cancer, and personally as trainees and collaborators who at present serv...
Mechanisms of RET mediated signal transduction.
Neuroendocrine TumorsThe RET receptor tyrosine kinase is physiologically stimulated by growth factors belonging to the glial cell line-derived neurotrophic factor (GDNF...
AGO2 protein: a key enzyme in the miRNA pathway as a novel biomarker in adrenocortical carcinoma.
Neuroendocrine TumorsAdrenocortical carcinoma (ACC) is a rare and aggressive malignancy characterised by diagnostic challenges, high recurrence rates, and poor prognosi...
Genotype/phenotype correlations in multiple endocrine neoplasia type 2.
Neuroendocrine TumorsMultiple endocrine neoplasia type 2 (MEN 2) is a rare hereditary endocrine tumour syndrome caused by mutations in the rearranged during transfectio...
Reappraisal of BRAFK601E-positive thyroid tumors in the NIFTP era.
Neuroendocrine TumorsBRAFK601E is an uncommon mutation typically found in encapsulated follicular-patterned thyroid tumors. Previous studies on BRAFK601E-positive thyro...
Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma.
Neuroendocrine TumorsMeasurement of thyroglobulin in fine needle aspirates (FNA-Tg) is useful for the diagnosis of lymph node metastasis in thyroid carcinoma; however, ...
Body composition in recurrent prostate cancer and the role of steroidogenic genotype.
Neuroendocrine TumorsHormone therapy (HT) to treat prostate cancer is reported to cause adverse changes in body composition. Clinically, interpatient body composition c...